Tag: somatostatin analog therapy
![michael farris golden rule](https://www.carcinoid.org/wp-content/uploads/2015/06/michael-farris-golden-rule.jpg)
DENIED: Michael Farris’ Journey with Insurance for Neuroendocrine Cancer Treatment
June 8, 2015
The good news is the very positive result at the end – but the road to getting insurance coverage for Michael Farris’ participation in the PRRT (peptide receptor radionuclide therapy) clinical trial at Excel Diagnostics in Houston, Texas, was fraught…
READ MORE![telotristat etiprate clinical trial](https://www.carcinoid.org/wp-content/uploads/2013/11/telotristat-etiprate-clinical-trial.jpg)
Discover Something New in Carcinoid Syndrome
November 11, 2013
For patients who suffer from carcinoid syndrome – with symptoms such as diarrhea, frequent bowel movements, abdominal pain, and flushing – that is not adequately controlled by their current somatostatin analog therapy, there is an opportunity to participate…
READ MORE